A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy-Reference-Cited by-同舟云学术

A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy

Published:2021-06 Issue: Volume:182 Page:106402
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Cantor Jerome O.,Ma Shuren,Liu Xingjian,Campos Michael A.,Strange Charlton,Stocks James M.,Devine Megan S.,El Bayadi Sherif G.,Lipchik Randolph J.^ORCID,Sandhaus Robert A.,Turino Gerard M.

Funder

Alpha-1 Foundation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference37 articles.

1. The pathology of chronic obstructive pulmonary disease;Hogg;Annu. Rev. Pathol.,2009

2. Pathogenesis of chronic obstructive pulmonary disease;Tuder;J. Clin. Invest.,2012

3. AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD;Kuna;Respir. Med.,2012

4. Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase;Lucas;Med. Res. Rev.,2013

5. Neutrophil elastase inhibitors;Groutas;Expert Opin. Ther. Pat.,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximizing the Therapeutic Effect of Endothelin Receptor Antagonists in Pulmonary Fibrosis: A Paradigm for Treating the Disease;International Journal of Molecular Sciences;2024-04-10

2. Desmosine as a biomarker for the emergent properties of pulmonary emphysema;Frontiers in Medicine;2023-12-18

3. Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Emphysema;American Journal of Respiratory Cell and Molecular Biology;2023-11

4. The relationship between elastin cross linking and alveolar wall rupture in human pulmonary emphysema;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-06-01

5. Performance and biocompatibility of a novel inhalable dry powder formulation based on hyaluronic acid intended to protect the respiratory tract mucosa;International Journal of Pharmaceutics;2023-05